Thursday is an important day for the US stock market. Here's why

The US stock market will reach a key inflection point tonight that could set the tone for ASX shares for the rest of the year.

| More on:
Piggy bank on US flag with stock market data.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The US stock market is coming to an inflection point with the Fed almost certain to announce another interest rate hike 
  • High profile economist Nouriel Roubini is forecasting a hard landing for the US economy that will trigger a 40% crash in the S&P 500 
  • The market is fully pricing in a 75 basis point rate hike with a 16% chance that the Fed will lift rates by 100 basis points 

The US stock market will reach a key inflection point tonight that could set the tone for ASX shares for the rest of the year.

The US Federal Reserve will be handing down its interest rate decision on Thursday with the market fully pricing in a 75-basis point (bp) hike.

If that comes to pass, it will be the Fed's third three-quarter point hike and would lift the Fed Funds Rate from 3% to 3.25%. That would be the highest since the start of the GFC in 2008!

What is spooking the US stock market?

But the Fed could be even more aggressive. The futures market is pricing in a 16% chance that the Fed could hike by a full percentage point, reported Reuters.

The US stock market is on tenterhooks. Investors are split over whether the Fed will hike rates to a point that will trigger a recession.

Adding to the angst is the prediction by "Dr. Doom", Nouriel Roubini, that the US and the world is facing a "long and ugly" recession, reported Bloomberg.

Dr. Doom's warning of a 40% crash in the US stock market

In fact, the economist believes the S&P 500 Index (SP: .INX) will crash by 40% if the US economy comes in for a hard landing. Make no mistake, the S&P/ASX 200 Index (ASX: XJO) won't be spared even if our economy holds up better.

Roubini correctly forecasted the GFC to earn his nickname. He said:

Even in a plain vanilla recession, the S&P 500 can fall by 30 per cent…It's not going to be a short and shallow recession, it's going to be severe, long and ugly.

How high can the Fed go?

His pessimism is premised on the Fed hiking rates to a peak of 5% in this cycle. That's well above expectations that the central bank will top out at a little over 4% before cutting rates next year to stave off a bad recession.

But Fed Chair Jerome Powell may not have that luxury as Dr. Doom reckons achieving a 2% inflation rate without a hard landing will be "mission impossible".

While there are early signs that inflation is easing, economists are divided on how quickly price pressures will ease.

ASX shares to feel the heat

If the Fed were to lift borrowing costs by more than expected, it will put pressure on our RBA to be more hawkish. Our reserve bank may be independent, but as a player in the global economy, relative rates matter more than the RBA cares to admit.

The US stock market is yet to price in 5% interest rates, let alone a long hard recession. This is why investors will be hanging on to Powell's every word tonight.

ASX investors will have a fretful 48 hours though as we have been "blessed" with a public holiday tomorrow.

The earliest we can react to the Fed's decision will be Friday, although Victoria will be on another holiday.

Go Cats!

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

Woman calculating dividends on calculator and working on a laptop.
Share Market News

Charter Hall Group declares interim distribution for 1H FY26

Charter Hall Group declares a 24.83-cent half-year distribution for the six months to 31 December 2025, with most of it…

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Andean Silver, Boss Energy, Chalice Mining, and Rio Tinto shares are falling today

These shares are starting the week in the red. But why?

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Broker Notes

Up 300% this year, 3 reasons to buy this ASX All Ords gold stock today

A leading broker sees further ‘clear upside’ potential for this rocketing ASX gold stock.

Read more »

asx silver shares represented by silver bull statue next to silver bear statue
Share Fallers

Up 118% in 2025, why is this All Ords ASX silver share crashing on Monday?

Investors are punishing this outperforming ASX silver share today. But why?

Read more »

A couple sit in their home looking at a phone screen as if discussing a financial matter.
Share Market News

APA Group gains $1bn extra funding capacity after S&P credit rating change

S&P’s credit rating change gives APA Group over $1 billion in extra capacity to fund new energy infrastructure projects.

Read more »

two men in suits shake hands at the top of a shined wood boardroom table.
Share Market News

DigiCo Infrastructure REIT appoints new CEO and sets strategic growth path

DigiCo Infrastructure REIT has appointed Michael Juniper as CEO, with a focus on powering the next phase of digital infrastructure…

Read more »

Four smiling young medics with arms crossed stand outside a hospital.
Share Market News

Telix Pharmaceuticals updates investors as first patient is dosed in Phase 3 prostate cancer trial

Telix Pharmaceuticals updates on its prostate cancer Phase 3 trial, dosing the first Part 2 patient and outlining regulatory plans.

Read more »